UniProt ID | ARPC5_HUMAN | |
---|---|---|
UniProt AC | O15511 | |
Protein Name | Actin-related protein 2/3 complex subunit 5 | |
Gene Name | ARPC5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 151 | |
Subcellular Localization | Cytoplasm, cytoskeleton . Cell projection . | |
Protein Description | Functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks.. | |
Protein Sequence | MSKNTVSSARFRKVDVDEYDENKFVDEEDGGDGQAGPDEGEVDSCLRQGNMTAALQAALKNPPINTKSQAVKDRAGSIVLKVLISFKANDIEKAVQSLDKNGVDLLMKYIYKGFESPSDNSSAMLLQWHEKALAAGGVGSIVRVLTARKTV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSKNTVSSA ------CCCCCCCCC | 34.31 | 22814378 | |
3 | Sumoylation | -----MSKNTVSSAR -----CCCCCCCCCC | 56.17 | - | |
3 | Ubiquitination | -----MSKNTVSSAR -----CCCCCCCCCC | 56.17 | 24816145 | |
3 | Acetylation | -----MSKNTVSSAR -----CCCCCCCCCC | 56.17 | 25953088 | |
3 | Sumoylation | -----MSKNTVSSAR -----CCCCCCCCCC | 56.17 | - | |
5 | Phosphorylation | ---MSKNTVSSARFR ---CCCCCCCCCCEE | 26.04 | 30257219 | |
5 | O-linked_Glycosylation | ---MSKNTVSSARFR ---CCCCCCCCCCEE | 26.04 | 30379171 | |
7 | Phosphorylation | -MSKNTVSSARFRKV -CCCCCCCCCCEEEC | 19.08 | 29514088 | |
8 | O-linked_Glycosylation | MSKNTVSSARFRKVD CCCCCCCCCCEEECC | 21.08 | 30379171 | |
8 | Phosphorylation | MSKNTVSSARFRKVD CCCCCCCCCCEEECC | 21.08 | 29514088 | |
13 | Ubiquitination | VSSARFRKVDVDEYD CCCCCEEECCHHHCC | 39.82 | 33845483 | |
19 (in isoform 2) | Phosphorylation | - | 24.88 | 27642862 | |
19 | Phosphorylation | RKVDVDEYDENKFVD EECCHHHCCCCCCCC | 24.88 | 28796482 | |
23 | Ubiquitination | VDEYDENKFVDEEDG HHHCCCCCCCCCCCC | 44.72 | 29967540 | |
23 | Sumoylation | VDEYDENKFVDEEDG HHHCCCCCCCCCCCC | 44.72 | - | |
44 | Phosphorylation | PDEGEVDSCLRQGNM CCCCCHHHHHHHCCH | 21.89 | - | |
51 | Sulfoxidation | SCLRQGNMTAALQAA HHHHHCCHHHHHHHH | 3.27 | 21406390 | |
60 (in isoform 1) | Ubiquitination | - | 63.78 | 21890473 | |
60 | Ubiquitination | AALQAALKNPPINTK HHHHHHHHCCCCCCC | 63.78 | 21906983 | |
67 (in isoform 1) | Ubiquitination | - | 35.76 | 21890473 | |
67 | Ubiquitination | KNPPINTKSQAVKDR HCCCCCCCHHHHHHH | 35.76 | 21906983 | |
67 | Acetylation | KNPPINTKSQAVKDR HCCCCCCCHHHHHHH | 35.76 | 25953088 | |
70 | Ubiquitination | PINTKSQAVKDRAGS CCCCCHHHHHHHHHH | 19.88 | 27667366 | |
70 (in isoform 2) | Ubiquitination | - | 19.88 | 21890473 | |
72 | Ubiquitination | NTKSQAVKDRAGSIV CCCHHHHHHHHHHHH | 44.50 | 22505724 | |
74 | Methylation | KSQAVKDRAGSIVLK CHHHHHHHHHHHHHH | 34.82 | - | |
75 | Ubiquitination | SQAVKDRAGSIVLKV HHHHHHHHHHHHHHH | 26.64 | 23503661 | |
77 | Phosphorylation | AVKDRAGSIVLKVLI HHHHHHHHHHHHHHH | 14.45 | 28355574 | |
80 (in isoform 2) | Phosphorylation | - | 2.79 | 27251275 | |
85 | Phosphorylation | IVLKVLISFKANDIE HHHHHHHHCHHCHHH | 19.28 | 24719451 | |
87 | Ubiquitination | LKVLISFKANDIEKA HHHHHHCHHCHHHHH | 39.22 | 33845483 | |
87 | Acetylation | LKVLISFKANDIEKA HHHHHHCHHCHHHHH | 39.22 | 25953088 | |
87 | Malonylation | LKVLISFKANDIEKA HHHHHHCHHCHHHHH | 39.22 | 26320211 | |
90 | Ubiquitination | LISFKANDIEKAVQS HHHCHHCHHHHHHHH | 56.11 | 33845483 | |
93 | Ubiquitination | FKANDIEKAVQSLDK CHHCHHHHHHHHHHH | 54.94 | 21906983 | |
93 | Acetylation | FKANDIEKAVQSLDK CHHCHHHHHHHHHHH | 54.94 | 25953088 | |
93 (in isoform 1) | Ubiquitination | - | 54.94 | 21890473 | |
96 | Ubiquitination | NDIEKAVQSLDKNGV CHHHHHHHHHHHCCH | 43.04 | 29967540 | |
96 (in isoform 2) | Ubiquitination | - | 43.04 | 21890473 | |
100 | Ubiquitination | KAVQSLDKNGVDLLM HHHHHHHHCCHHHHH | 61.98 | 22505724 | |
103 | Ubiquitination | QSLDKNGVDLLMKYI HHHHHCCHHHHHHHH | 7.01 | 22505724 | |
108 (in isoform 1) | Ubiquitination | - | 28.59 | 21890473 | |
108 | Ubiquitination | NGVDLLMKYIYKGFE CCHHHHHHHHHHCCC | 28.59 | 21906983 | |
111 | Ubiquitination | DLLMKYIYKGFESPS HHHHHHHHHCCCCCC | 11.28 | 21963094 | |
111 (in isoform 2) | Ubiquitination | - | 11.28 | 21890473 | |
112 (in isoform 1) | Ubiquitination | - | 47.79 | 21890473 | |
112 | Ubiquitination | LLMKYIYKGFESPSD HHHHHHHHCCCCCCC | 47.79 | 22817900 | |
115 | Ubiquitination | KYIYKGFESPSDNSS HHHHHCCCCCCCCHH | 71.10 | 22817900 | |
115 (in isoform 2) | Ubiquitination | - | 71.10 | 21890473 | |
116 | Phosphorylation | YIYKGFESPSDNSSA HHHHCCCCCCCCHHH | 27.69 | 27251275 | |
118 | Phosphorylation | YKGFESPSDNSSAML HHCCCCCCCCHHHHH | 59.72 | 22199227 | |
119 (in isoform 2) | Phosphorylation | - | 63.52 | 27251275 | |
121 | Phosphorylation | FESPSDNSSAMLLQW CCCCCCCHHHHHHHH | 25.19 | 22199227 | |
122 | Phosphorylation | ESPSDNSSAMLLQWH CCCCCCHHHHHHHHH | 24.77 | 22199227 | |
124 | Sulfoxidation | PSDNSSAMLLQWHEK CCCCHHHHHHHHHHH | 4.08 | 30846556 | |
131 | Ubiquitination | MLLQWHEKALAAGGV HHHHHHHHHHHCCCH | 35.49 | 22817900 | |
131 (in isoform 1) | Ubiquitination | - | 35.49 | 21890473 | |
134 (in isoform 2) | Ubiquitination | - | 14.66 | 21890473 | |
134 | Ubiquitination | QWHEKALAAGGVGSI HHHHHHHHCCCHHHH | 14.66 | 21890473 | |
140 | Phosphorylation | LAAGGVGSIVRVLTA HHCCCHHHHHHHHHC | 18.59 | 23312004 | |
146 | Phosphorylation | GSIVRVLTARKTV-- HHHHHHHHCCCCC-- | 22.89 | 23882029 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARPC5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARPC5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...